Recent Center News
Sarah Perry to Receive American Chemical Society Young Investigator Award
Sarah Perry, associate professor in the Department of Chemical Engineering, Center for Bioactive Delivery, Models to Medicine Center, has been chosen as one of two national recipients of the 2024 American Chemical Society (ACS) Macro Letters/Biomacromolecules/Macromolecules Young Investigator Award for her contributions to the field of polyelectrolyte self-assembly and the incorporation of proteins into these assemblies.
Martin and Perry to Help Launch the Future of RNA Research and Biomedicine
Craig Martin, professor of chemistry, Models to Medicine Center, and Sarah Perry, associate professor of chemical engineering, Center for Bioactive Delivery, recently received support from the National Institutes of Health (NIH) to develop an innovative approach toward efficiently, reliably and cost effectively synthesizing novel strands of specialty “long RNA.” Future genetic research into everything from basic cell biology to advanced therapeutics depends in part on having just the sort of complex, modified RNA that Martin and Perry will be working to make widely available.
IALS Interview with Elena Pobezinskaya
Elena Pobezinskaya is a faculty member in the Department of Veterinary and Animal Sciences and member of the Center for Bioactive Delivery and the Models to Medicine Center.
IALS Announces Inaugural Graduate Student Fellows for 2024
IALS is excited to announce the inaugural one-year translational Graduate Student Fellows for 2024!
We define translational research as work that aims to inform or to develop product candidates, technologies, and services that deliver benefits to human health and well-being.
CBD’s Pobezinsky and Pobezinskaya Use Flow Cytometry to Determine How Tumor Cells Outwit the Body’s Immune System
In a first-of-its-kind research breakthrough, a team of UMass scientists including the Center for Bioactive Delivery's (CBD) Leonid Pobezinsky and Elena Pobezinskaya have analyzed and described what they call the “mosquito effect,” which sheds light on how certain pathogens, such as cancerous tumor cells, can outwit the body’s immune system.